Khalife N - Search Results

1

Pembrolizumab: a new standard of care in metastatic colorectal cancer.

Saleh K, Kordahi M, Felefly T, Khalife N. Saleh K, et al. Among authors: khalife n. Immunotherapy. 2021 Oct;13(15):1245-1247. doi: 10.2217/imt-2021-0051. Epub 2021 Sep 20. Immunotherapy. 2021. PMID: 34542319 No abstract available.

2

Characteristics of incident female breast cancer in Lebanon, 1990-2013: Descriptive study of 612 cases from a hospital tumor registry.

Chahine G, El Rassy E, Khazzaka A, Saleh K, Rassy N, Khalife N, Atallah D. Chahine G, et al. Among authors: khalife n. Cancer Epidemiol. 2015 Jun;39(3):303-6. doi: 10.1016/j.canep.2015.03.008. Epub 2015 Mar 29. Cancer Epidemiol. 2015. PMID: 25828075

3

Late Recurrence of Low-Risk Stage II Colorectal Cancer Shortly After Etanercept.

Ibrahim T, Saleh K, Track-Smayra V, Ziade N, Sarraf D, Yazbeck C, Khalife N, Nasr F. Ibrahim T, et al. Among authors: khalife n. J Gastrointest Cancer. 2016 Dec;47(4):506-508. doi: 10.1007/s12029-015-9788-y. J Gastrointest Cancer. 2016. PMID: 26691174 No abstract available.

4

Febuxostat-associated eosinophilic polymyositis in marginal zone lymphoma.

Chahine G, Saleh K, Ghorra C, Khoury N, Khalife N, Fayad F. Chahine G, et al. Among authors: khalife n. Joint Bone Spine. 2017 Mar;84(2):221-223. doi: 10.1016/j.jbspin.2016.10.008. Epub 2016 Dec 7. Joint Bone Spine. 2017. PMID: 27955822

5

Chemotherapy-free regimen: a new hope in Philadelphia-positive acute lymphoblastic leukemia.

Saleh K, Chahine C, Khalife N. Saleh K, et al. Among authors: khalife n. Future Oncol. 2021 Apr;17(11):1265-1267. doi: 10.2217/fon-2020-1220. Epub 2021 Feb 12. Future Oncol. 2021. PMID: 33573414 No abstract available.

6

RET fusions in non-small-cell lung cancer: an emerging target reshaping the treatment paradigm.

Saleh K, Khalife N, Felefly T. Saleh K, et al. Among authors: khalife n. Future Oncol. 2021 Apr;17(12):1445-1448. doi: 10.2217/fon-2020-1297. Epub 2021 Feb 12. Future Oncol. 2021. PMID: 33573417 No abstract available.

7

Rearranged-in-transfection inhibitors: emerging agnostic targeted therapies for solid tumors.

Saleh K, Felefly T, Khalife N, Kourie HR. Saleh K, et al. Among authors: khalife n. Pharmacogenomics. 2021 Apr;22(5):247-250. doi: 10.2217/pgs-2021-0002. Epub 2021 Mar 23. Pharmacogenomics. 2021. PMID: 33754802 No abstract available.

8

Cemiplimab: a new option for the treatment of non-small-cell lung cancer.

Khalife N, Kordahi M, Felefly T, Saleh K. Khalife N, et al. Future Oncol. 2021 Jul;17(20):2559-2562. doi: 10.2217/fon-2021-0343. Epub 2021 May 28. Future Oncol. 2021. PMID: 34047193 No abstract available.

9

KRAS-targeted therapies in advanced solid cancers: drug the undruggable?

Saleh K, Kordahi M, Felefly T, Kourie HR, Khalife N. Saleh K, et al. Among authors: khalife n. Pharmacogenomics. 2021 Jul;22(10):587-590. doi: 10.2217/pgs-2021-0045. Epub 2021 Jun 21. Pharmacogenomics. 2021. PMID: 34148378 No abstract available.

10

Urothelial carcinoma in the era of immune checkpoint inhibitors.

Khalife N, Chahine C, Kordahi M, Felefly T, Kourie HR, Saleh K. Khalife N, et al. Immunotherapy. 2021 Aug;13(11):953-964. doi: 10.2217/imt-2021-0042. Epub 2021 Jun 29. Immunotherapy. 2021. PMID: 34184561 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters